Eladynos
abaloparatide
Osteoporosis, Postmenopausal
Osteoporosis
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanAuthorised
EMEA-002440-PIP01-18-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: P/0098/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Granules for oral suspension
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Xofluza
baloxavir marboxil
Influenza, Human
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanAuthorised
Eladynos
abaloparatide
Osteoporosis
Date of refusal:
Last updated:
MedicineHumanRefused
EMEA-001667-PIP01-14 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/0307/2014
Route(s) of administration: Subcutaneous useTransdermal use
Pharmaceutical form(s):
Solution for injection
Transdermal system
Decision date:
Last updated:
Compliance check: ✖
PIPHuman